• OPEN AN ACCOUNT
Indian Indices
Sensex
73,758.40 -94.50
( -0.13%)
Global Indices
Nasdaq
52,511.77 524.74
(1.01%)
Dow Jones
7,731.20 19.47
(0.25%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,731.75 -32.94
(-0.31%)
Forex
USD-INR
94.90 0.12
(0.13%)
EUR-INR
106.44 -0.03
(-0.02%)
GBP-INR
126.38 0.12
(0.10%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
48.09
1160.13
EPS(TTM)
Face Value()
Div & Yield %
20.47
10
0.05
 

Shriram Finance changes name of subsidiary to Shriram Gilts
Oct 16,2026
Shriram Finance announced that based on the No Objection received from Reserve Bank of India, the name of wholly owned subsidiary of the Company has been changed from “Shriram Overseas Investments” to “Shriram Gilts” with effect from 15 October 2026 as approved by Ministry of Corporate Affairs (MCA).